BC PAD Education. Free Continuing Education Sessions for Clinicians - Medication for Menopause Associated Vasomotor and Genitourinary Symptoms.
Participants will have the opportunity to apply current evidence and practical drug information to support shared-decision making regarding:
- Estrogen and progestogen products: most commonly prescribed in B.C. for vasomotor and genitourinary symptoms (oral, transdermal, vaginal).
- Fezolinetant: the first non-hormonal medication approved by Health Canada for vasomotor symptoms.
- Transdermal testosterone: for hypoactive sexual desire disorder.